2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Megan Kruse, MD, discusses how socioeconomic disparities and access to health insurance can contribute to poorer overall survival (OS) outcomes in adolescent patients with invasive breast cancer.
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Megan Kruse, MD, medical oncologist, Cleveland Clinic, discusses how socioeconomic disparities and access to health insurance can contribute to poorer overall survival (OS) outcomes in adolescent patients with invasive breast cancer.
A retrospective analysis of 18,018 adolescent or young adult patients with invasive breast cancer indicated that low socioeconomic status and public insurance was associated with decreased OS rates vs patients with a higher median income or those with private insurance. These data help identify specific patient populations that would benefit from improved treatment accessibility, Kruse says.
Additionally, this population is at higher-risk for developing aggressive breast cancer subtypes, such as triple-negative or HER2-positive disease. Further investigation into potential confounding variables may promote a better understanding of the relationship between social determinants and worsened survival outcomes, Kruse concludes.
Related Content: